Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial

Taispeáin leaganacha eile (1)

<strong>Background<br></strong> Methotrexate is the first-line treatment for immune-mediated inflammatory diseases and reduces vaccine-induced immunity. We evaluated if a 2-week interruption of methotrexate treatment immediately after COVID-19 booster vaccination improved antibody...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Abhishek, A, Peckham, N, Pade, C, Gibbons, JM, Cureton, L, Francis, A, Barber, V, Williams, JAE, Appelbe, D, Eldridge, L, Julier, P, Altmann, DM, Bluett, J, Brooks, T, Coates, LC, Rombach, I, Semper, A, Otter, A, Valdes, AM, Nguyen-Van-Tam, JS, Williams, HC, Boyton, RJ, McKnight, Á, Cook, JA
Rannpháirtithe: VROOM study investigators
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: Elsevier 2023

Míreanna comhchosúla